Skip to main content
. 2019 Oct 25;173(1):156–170. doi: 10.1093/toxsci/kfz213

Figure 3.

Figure 3.

Y-maze. Both control (saline-treated) and CMF-treated groups spent significantly more time exploring the novel arm during the testing phase of the Y-maze, indicating no short-term memory deficits. Error bars are mean ± SEM (n = 10); ***P <.001; ****P <.0001.